120 related articles for article (PubMed ID: 9361966)
1. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity.
Jackson A; McSherry C; Butters K; Diko M; Almond PS; Matas AJ; Reinsmoen NL
Hum Immunol; 1997 Jul; 55(2):148-53. PubMed ID: 9361966
[TBL] [Abstract][Full Text] [Related]
2. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
Reinsmoen NL; Matas AJ
Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients.
McSherry C; Hertz MI; Jackson AM; Butters K; Diko M; Matas AJ; Bolman RM; Reinsmoen NL
Clin Transplant; 1995 Dec; 9(6):442-9. PubMed ID: 8645886
[TBL] [Abstract][Full Text] [Related]
4. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity.
Reinsmoen NL; Bolman RM; Savik K; Butters K; Matas AJ; Hertz MI
J Heart Lung Transplant; 1994; 13(1 Pt 1):30-6; discussion 36-7. PubMed ID: 7513186
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
[TBL] [Abstract][Full Text] [Related]
6. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients.
Reinsmoen NL; Jackson A; McSherry C; Ninova D; Wiesner RH; Kondo M; Krom RA; Hertz MI; Bolman RM; Matas AJ
Transplantation; 1995 Dec; 60(12):1546-54. PubMed ID: 8545888
[TBL] [Abstract][Full Text] [Related]
7. Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients.
Reinsmoen NL; McSherry C; Chavers B; Hertz MI; Matas AJ
Pediatr Nephrol; 1995; 9 Suppl():S35-9. PubMed ID: 7492484
[TBL] [Abstract][Full Text] [Related]
8. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.
Lagaaij EL; Hennemann IP; Ruigrok M; de Haan MW; Persijn GG; Termijtelen A; Hendricks GF; Weimar W; Claas FH; van Rood JJ
N Engl J Med; 1989 Sep; 321(11):701-5. PubMed ID: 2671729
[TBL] [Abstract][Full Text] [Related]
9. An apparent paradoxical effect of pretransplant blood transfusions. Its association with decreased anti-HLA antibody formation following unsuccessful renal transplantation.
Lobo PI
Transplantation; 1984 Jun; 37(6):562-4. PubMed ID: 6375015
[TBL] [Abstract][Full Text] [Related]
10. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients.
Reinsmoen NL; Kaufman D; Matas A; Sutherland DE; Najarian JS; Bach FH
Transplantation; 1990 Nov; 50(5):783-90. PubMed ID: 2146784
[TBL] [Abstract][Full Text] [Related]
11. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.
Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S
Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098
[TBL] [Abstract][Full Text] [Related]
12. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific cytotoxic T lymphocyte hyporesponsiveness following renal transplantation in patients pretreated with donor-specific transfusions.
Grailer AP; Sollinger HW; Kawamura T; Burlingham WJ
Transplantation; 1991 Feb; 51(2):320-4. PubMed ID: 1825241
[TBL] [Abstract][Full Text] [Related]
14. Impact of transfusions and acute rejection on posttransplantation donor antigen-specific responses in two study populations. Cooperative Clinical Trial in Transplantation Research Group.
Reinsmoen NL; Matas AJ; Donaldson L; Carter S
Transplantation; 1999 Mar; 67(5):697-702. PubMed ID: 10096524
[TBL] [Abstract][Full Text] [Related]
15. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
[TBL] [Abstract][Full Text] [Related]
16. Importance of HLA-DR matching in polytransfused cadaveric kidney transplant recipients. A prospective one-center study.
Vanrenterghem Y; Vandeputte I; Lerut T; Roels L; Gruwez J; Michielsen P
Transplantation; 1983 Oct; 36(4):384-7. PubMed ID: 6353705
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.
Eikmans M; Waanders MM; Roelen DL; van Miert PP; Anholts JD; de Fijter HW; Brand A; Claas FH
Transplantation; 2010 Dec; 90(11):1192-9. PubMed ID: 21166103
[TBL] [Abstract][Full Text] [Related]
18. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft.
Middleton D; Martin J; Douglas J; McClelland M
Transplantation; 1994 Oct; 58(7):845-8. PubMed ID: 7940720
[TBL] [Abstract][Full Text] [Related]
19. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
[TBL] [Abstract][Full Text] [Related]
20. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O
Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
